A majority of biopharmas are expected to increase their reliance on CDMOs in coming years despite rising costs for their ...

A Samsung Biologics’ spokesperson stated that the company’s cumulative contract value surpasses $21.9 billion following the latest agreement.

Study findings might also help inform development of targeted treatments that destroy cancer cells while leaving normal tissue unharmed.

CloudScope, developed at Johns Hopkins, is a cloud-based microscope enabling continuous, remote brain imaging in freely ...

HiCB was developed to reduce cost of goods, lower capital investment, and enable agile production, according to Transcenta ...

Human genetic analysis found that rare and common coding variants in the MMP9 gene are associated with neuropathic pain ...

By cutting processing intensity and improving recovery, the technology strengthens the case for domestic biomanufacturing.

Medra, another physical AI company, has the ambitious goal of accelerating end-to-end drug discovery campaigns. Founder and ...

As one notable company exits the field, growing CDMOs open facilities and secure major contracts ...

The platform combines a human lymphoid organoid with a microfluidics-based vascularized microenvironment that mimics bone ...

MS is being leveraged to profile the metabolome and lipidome, providing insight into tumor metabolism and the surrounding microenvironments.

The DARPA project had the potential to improve athletic performance and help treat conditions involving a lack of oxygen in ...